SHIELD Illinois COVID Testing
The SHIELD program launched September 27 in all three BSD2 schools. It is now running smoothly across the District, so the District has reopened enrollment to allow additional students and staff to participate in the program.
Advantages of the Testing:
- Easy: your child will provide a saliva sample by spitting into a tube.
- Reliable: the District has partnered with the University of Illinois, developer of the SHIELD Illinois Rapid rtPC test (“Test”). The Test has very high reliability and approval from the FDA. You can read more about it here.
- Free: there’s no charge to you or the District.
- Peace of Mind: the Test makes everyone in District 2 safer by helping us identify COVID-19 cases as early as possible.
- Secure: test results are available only to the health staff and the school leadership. You can log on anytime to see your child’s results.
- Frequent: tests will usually be administered once or twice a week. You will be contacted if more frequent testing is proposed, such as for students who have been exposed to COVID.
What Does My Consent Mean?
- You authorize the District and its medical partner to collect saliva samples from your child and to share your child’s name and other test-related information as needed.
- You acknowledge that the District does not provide medical advice. If your child tests positive, you will need to consult your own medical provider about the next steps.
- Consent is voluntary.
- You can revoke your consent at any time by writing to your child’s principal or nurse. Until revoked, your consent remains valid for the 2021-22 school year.
How will Test Results be Handled?
- If your child tests positive, the School will contact you promptly by phone.
- Positive test results will be shared, as legally required, with the DuPage County Health Department. The DCHD will advise you about your child’s time at home and about protecting the rest of your household during that time.
- Click here to complete the consent form for minors undergoing COVID-19 testing.